Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Waller

Showing results (81-90 of 511) with videos related to

Pageof 52
Sort By:
Molecular Medicine (Cambridge, Mass.)|July 1, 1996
Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparinG Hartmann, A Krug, K Waller-Fontaine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trialsAnthea L Hammond, Edmund K Waller, Lee B Finkelstein
Lancet (London, England)|June 3, 1972
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinomaJ E Banatvala, J M Best, D K Waller
Oncoimmunology|June 23, 2017
Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemiaChristopher T Petersen, Jian-Ming Li, Edmund K Waller
Leukemia & Lymphoma|May 11, 2002
Induction of human herpesvirus 8 gene expression in a posttransplantation primary effusion lymphoma cell lineRenee N Shaw, Edmund K Waller, Margaret K Offermann
Experimental Hematology|June 27, 2006
Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMTJian-Ming Li, Cynthia R Giver, Edmund K Waller
Bone Marrow Transplantation|December 8, 2015
Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?J J Auletta, S M Devine, E K Waller
Current Opinion in Immunology|March 1, 2021
Indole derivatives, microbiome and graft versus host diseaseMuna Qayed, David Michonneau, Gerard Socié, et al.
Biology of Reproduction|June 1, 1986
Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cellsJ A Hettle, E K Waller, I B Fritz
The Journal of Experimental Medicine|July 1, 1993
Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediateD L Kraft, I L Weissman, E K Waller
Pageof 52

Showing results (81-90 of 511) with videos related to

Sort By:
Pageof 52
Molecular Medicine (Cambridge, Mass.)|July 1, 1996
Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparinG Hartmann, A Krug, K Waller-Fontaine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trialsAnthea L Hammond, Edmund K Waller, Lee B Finkelstein
Lancet (London, England)|June 3, 1972
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinomaJ E Banatvala, J M Best, D K Waller
Oncoimmunology|June 23, 2017
Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemiaChristopher T Petersen, Jian-Ming Li, Edmund K Waller
Leukemia & Lymphoma|May 11, 2002
Induction of human herpesvirus 8 gene expression in a posttransplantation primary effusion lymphoma cell lineRenee N Shaw, Edmund K Waller, Margaret K Offermann
Experimental Hematology|June 27, 2006
Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMTJian-Ming Li, Cynthia R Giver, Edmund K Waller
Bone Marrow Transplantation|December 8, 2015
Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?J J Auletta, S M Devine, E K Waller
Current Opinion in Immunology|March 1, 2021
Indole derivatives, microbiome and graft versus host diseaseMuna Qayed, David Michonneau, Gerard Socié, et al.
Biology of Reproduction|June 1, 1986
Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cellsJ A Hettle, E K Waller, I B Fritz
The Journal of Experimental Medicine|July 1, 1993
Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediateD L Kraft, I L Weissman, E K Waller
Pageof 52